“The Chinese unethical business custom will be an obstacle of entry for domestic pharmaceutical companies”

It is analyzed that unethical business customs in the pharmaceutical industry in China would be amajor obstacle for domestic pharmaceutical companies to enter in the non-tariff field.

Since many multinational pharmaceutical companies are openly performing lobbying activities on medical personnel and China has the climate to emphasize on personnel relations, it is argued that the circumstance i...